N. Zhou

发表

Impact of mechanical circulatory support and immunomodulation therapy on outcome of patients with fulminant myocarditis: Chinese registry of fulminant myocarditis

E. Ammirati, Daowen Wang, N. Zhou, 2021, Signal Transduction and Targeted Therapy.

Emerging role of VCP/p97 in cardiovascular diseases: novel insights and therapeutic opportunities

Daowen Wang, Yizhong Peng, N. Zhou, 2021, Biochemical Society transactions.

Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19

Hualiang Jiang, Jia Li, Daowen Wang, 2020, Science China Life Sciences.

Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis.

L. Cooper, K. Klingel, G. Veronese, 2020, International journal of cardiology.

Emerging Roles of Ceramide in Cardiovascular Diseases

Daowen Wang, Yizhong Peng, N. Zhou, 2022, Aging and disease.

Trimetazidine in Heart Failure

Daowen Wang, Yizhong Peng, N. Zhou, 2021, Frontiers in Pharmacology.

Clinical Implications of Nicorandil Combined with Trimetazidine in Patients with Coronary Heart Disease: A Real-World Observational Study

Lin Qiu, N. Zhou, Lan Shen, 2021, Advances in Therapy.

The role of CD36 in cardiovascular disease

Daowen Wang, Yizhong Peng, N. Zhou, 2020, Cardiovascular research.

Mortality and Pre‐Hospitalization use of Renin‐Angiotensin System Inhibitors in Hypertensive COVID‐19 Patients

J. Moslehi, E. Ammirati, G. Cui, 2020, Journal of the American Heart Association.

Trimetazidine enhances myocardial angiogenesis in pressure overload-induced cardiac hypertrophy mice through directly activating Akt and promoting the binding of HSF1 to VEGF-A promoter

Min Zhang, Daowen Wang, N. Zhou, 2022, Acta Pharmacologica Sinica.

A life support-based comprehensive treatment regimen dramatically lowers the in-hospital mortality of patients with fulminant myocarditis: a multiple center study

R. Hui, Daowen Wang, Sheng Li, 2019, Science China Life Sciences.

RBM20, a Therapeutic Target to Alleviate Myocardial Stiffness via Titin Isoforms Switching in HFpEF

N. Zhou, Hongyang Shu, Na Li, 2022, Frontiers in Cardiovascular Medicine.

Pirfenidone alleviates cardiac fibrosis induced by pressure overload via inhibiting TGF‐β1/Smad3 signalling pathway

N. Zhou, Hongyang Shu, Na Li, 2022, Journal of cellular and molecular medicine.

Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPK

Daowen Wang, Yizhong Peng, N. Zhou, 2021, Frontiers in Pharmacology.

In-hospital use of ACEI/ARB is associated with lower risk of mortality and critic illness in COVID-19 patients with hypertension

Siyuan Wang, N. Zhou, Sen Xu, 2020, Journal of Infection.

Statin Use and In-hospital Mortality in Patients with COVID-19 and Coronary Heart Disease

Ben He, Dong Liu, Ying Xiao, 2021, Scientific Reports.

Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases

Xin A. Zhang, Li Ni, Daowen Wang, 2020, Science China Life Sciences.

Focus on Autoimmune Myocarditis in Graves' Disease: A Case-Based Review

Wei Wang, Daowen Wang, Yan Wang, 2021, Frontiers in Cardiovascular Medicine.

Organ function support in patients with coronavirus disease 2019: Tongji experience

Jia Wei, Luyun Wang, Shui-ming Guo, 2020, Frontiers of Medicine.

A life support-based comprehensive treatment regimen dramatically lowers the in-hospital mortality of patients with fulminant myocarditis: a multiple center study

R. Hui, Daowen Wang, Sheng Li, 2019, Science China Life Sciences.

The Association of Low Molecular Weight Heparin Use and In-hospital Mortality Among Patients Hospitalized with COVID-19

E. Peterson, Ying Xiao, Daowen Wang, 2021, Cardiovascular Drugs and Therapy.

Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients

G. Veronese, J. Moslehi, E. Ammirati, 2020, Journal of Molecular and Cellular Cardiology.

COVID-19 and Cardiovascular Diseases: From Cellular Mechanisms to Clinical Manifestations

Zheng Wen, Daowen Wang, Yizhong Peng, 2023, Aging and disease.

Optimizing Management to Reduce the Mortality of COVID-19: Experience From a Designated Hospital for Severely and Critically Ill Patients in China

Daowen Wang, Jianping Zhao, Jihong Liu, 2021, Frontiers in Medicine.

Increased cardiac remodeling in cardiac-specific Flt-1 receptor knockout mice with pressure overload

Jiafeng Lin, M. Chu, N. Zhou, 2015, Cell and Tissue Research.

[Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19].

C Chen, J T Yan, N Zhou, 2020, Zhonghua xin xue guan bing za zhi.

Real-World Major Adverse Cardiovascular Events of Nicorandil and Nitrate in Coronary Heart Disease in Central China: A Retrospective Cohort Study

N. Zhou, Lan Shen, Juan Chen, 2023, Cardiology Discovery.

Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance

Jia Hua Cheng, Yan Wang, Yizhong Peng, 2023, Cardiovascular Diabetology.

Erratum to: Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19

Hualiang Jiang, Jia Li, Daowen Wang, 2020, Science China Life Sciences.